Albany Medical Center Participating in Clinical Trial Involving Use of Stem Cells to Improve Recovery of Stroke Survivors
June 20, 2019
June 20, 2019
ALBANY, New York, June 20 -- Albany Medical Center, an academic health sciences center, issued the following news release:
Albany Med has announced its participation in a new clinical research study that aims to improve function in people with chronic disability as a result of an ischemic stroke.
The study, called PISCES III, will research if an investigational drug product (DP) made from stem cells will help improve function in stroke survivors with limited movement in . . .
Albany Med has announced its participation in a new clinical research study that aims to improve function in people with chronic disability as a result of an ischemic stroke.
The study, called PISCES III, will research if an investigational drug product (DP) made from stem cells will help improve function in stroke survivors with limited movement in . . .